Nsaids GastropathyDyspepsia Upon Chronic Gastritis In Anamnesis In Patients With Osteoarthrosis
Journal: International Journal of Scientific & Technology Research (Vol.3, No. 12)Publication Date: 2014-12-15
Authors : M. Y. Zak; L. M. Pasiyeshvili; M. Y. Knysh;
Page : 197-199
Keywords : Index Terms Chronic Gastritis; NSAIDs Gastropathy; NSAIDs Dyspepsia.;
Abstract
Abstract 122 patients with osteoarthrosis who had verified chronic gastritis in the anamnesis 50 males and 72 females aged from 42 to 64 were examined. Control group included 40 patients with osteoarthrosis without gastroduodenal zone pathology in the anamnesis. For arthralgia relief patients were prescribed to intake meloxicam average dose 12.51.39 mgday or nimesulide average dose 15014.91 mgday. As a result of this research it was determined that prescription of selective NSAIDs meloxicam and nimesulide raised the risk of NSAIDs gastropathydyspepsia in 2.9 times P0.03 in patients with chronic gastritis in the anamnesis than in patients without associated gastroduodenal zone pathology. Atrophy of gastric mucous membrane was associated with higher risks P0.05 of erosive gastropathy. With the purpose of gastropathy prevention upon taking NSAIDs patients with chronic gastritis in the anamnesis are recommended to undergo gastroprotective therapy.
Other Latest Articles
- X-Ray Breast Brachytherapy Instead Of 192Ir Mammosite Balloon Brachytherapy
- Radiation Dosimetry By Tlds Inside Human Body Phantom While Using 192Ir HDR In Breast Brachytherapy
- Optimum Design Of Photovoltaic Powered Sea Water Desalination System
- The Effect of Strategic Partnership On Innovation Capability and Business Performance Of Garment Industry In West Java - Indonesia
- Decentralization And Women Empowerment In Bangladesh Union Parishad Perspectives
Last modified: 2015-06-28 04:04:25